Received May 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| VARCEL | VARICELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Has fever; swollen red itches injection site; swollen red itches injection site; swollen red itches injection site; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), in Apr2026 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; varicella zoster vaccine (VARICELLA VACCINE), in Apr2026 as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious) with onset Apr2026, outcome "unknown", described as "Has fever"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PRURITUS (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset Apr2026, outcome "unknown" and all described as "swollen red itches injection site". Additional information: The patient reported having received shingles and COVID 19 vaccines two days earlier and subsequently experienced fever along with swelling, redness, and itching at the injection site. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.